SLP250 (R), n=1 cell(s)

Main group: Visual Projection Neurons; Neurotransmitter consensus prediction: unclear

Mean synapse counts per layer

  LA
Post -
Pre -
  M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 Total
0 6.0 - 1.0 1.0 5.0 45.0 66.0 16.0 - - 140
1 - - - - - 5.0 16.0 - - - 21
  LO1 LO2 LO3 LO4 LO5a LO5b LO6 Total
Post - - - - - - 107.0 107.0
Pre - - - - - - - -
  AME
0 416
1 16
  LOP1 LOP2 LOP3 LOP4 Total
Post - - - - -
Pre - - - - -
  central brain
0 956
1 748

Neuron visualizations

Population spatial coverage

Medulla

Number of post synapses:140
Number of pre synapses:21
Number of output connections:28
Coverage factor:1.0
Columnar completeness:0.04
Area completeness:0.11
Cell size (columns):40

Lobula

Number of post synapses:107
Number of pre synapses:0
Number of output connections:0
Coverage factor:1.0
Columnar completeness:0.05
Area completeness:0.32
Cell size (columns):44

Lobula Plate

Number of post synapses:0
Number of pre synapses:0
Number of output connections:0
Coverage factor:0
Columnar completeness:0
Area completeness:0
Cell size (columns):0

Optic Lobe Connectivity

Inputs

  instance NT total connections connections /#SLP250 (R) % % cumu.
0 aMe3 (R) Glu 136 136.0 14.5% 14.5%
1 MeLo1 (R) ACh 134 134.0 14.3% 28.9%
2 aMe1 (R) GABA 133 133.0 14.2% 43.1%
3 MeVPMe4 (L) Glu 34 34.0 3.6% 46.7%
4 HBeyelet (R) His 27 27.0 2.9% 49.6%
5 MeVPaMe2 (L) Glu 26 26.0 2.8% 52.4%
6 aMe2 (R) Glu 25 25.0 2.7% 55.1%
7 Mi10 (R) ACh 24 24.0 2.6% 57.6%
8 OCG02c (L) unclear 21 21.0 2.2% 59.9%
9 aMe6a (R) ACh 20 20.0 2.1% 62.0%
10 aMe12 (R) ACh 19 19.0 2.0% 64.1%
11 aMe5 (R) ACh 19 19.0 2.0% 66.1%
12 aMe6b (R) ACh 17 17.0 1.8% 67.9%
13 DNpe053 (R) ACh 15 15.0 1.6% 69.5%
14 MeTu4f (R) ACh 15 15.0 1.6% 71.1%
15 DNpe053 (L) ACh 14 14.0 1.5% 72.6%
16 MeVPMe11 (L) Glu 14 14.0 1.5% 74.1%
17 MeLo6 (R) ACh 10 10.0 1.1% 75.2%
18 aMe9 (R) ACh 8 8.0 0.9% 76.0%
19 MeVP1 (R) ACh 8 8.0 0.9% 76.9%
20 aMe4 (R) ACh 7 7.0 0.7% 77.6%
21 aMe9 (L) ACh 7 7.0 0.7% 78.4%
22 Cm17 (R) GABA 7 7.0 0.7% 79.1%
23 aMe26 (R) ACh 6 6.0 0.6% 79.8%
24 MeVC21 (R) Glu 6 6.0 0.6% 80.4%
25 OA-AL2i3 (R) OA 6 6.0 0.6% 81.1%
26 5thsLNv_LNd6 (R) ACh 5 5.0 0.5% 81.6%
27 Cm12 (R) GABA 5 5.0 0.5% 82.1%
28 LC41 (R) ACh 5 5.0 0.5% 82.7%
29 MeLo5 (R) ACh 5 5.0 0.5% 83.2%
30 MeTu1 (R) ACh 5 5.0 0.5% 83.7%
31 MeVC_unclear (R) Glu 5 5.0 0.5% 84.3%
32 MeVP45 (R) ACh 5 5.0 0.5% 84.8%
33 MeVP63 (R) GABA 5 5.0 0.5% 85.3%
34 MeVPMe6 (L) Glu 5 5.0 0.5% 85.9%
35 Tm38 (R) ACh 5 5.0 0.5% 86.4%
36 aMe12 (L) ACh 4 4.0 0.4% 86.8%
37 aMe30 (R) Glu 4 4.0 0.4% 87.3%
38 L3 (R) ACh 4 4.0 0.4% 87.7%
39 MeTu4c (R) ACh 4 4.0 0.4% 88.1%
40 MeVP7 (R) ACh 4 4.0 0.4% 88.6%
41 Cm24 (R) Glu 3 3.0 0.3% 88.9%
42 Cm30 (R) GABA 3 3.0 0.3% 89.2%
43 LoVP46 (R) Glu 3 3.0 0.3% 89.5%
44 LoVP62 (R) ACh 3 3.0 0.3% 89.8%
45 MeLo7 (R) ACh 3 3.0 0.3% 90.2%
46 MeVC22 (R) Glu 3 3.0 0.3% 90.5%
47 MeVC23 (R) Glu 3 3.0 0.3% 90.8%
48 MeVP12 (R) ACh 3 3.0 0.3% 91.1%
49 MeVP14 (R) ACh 3 3.0 0.3% 91.4%
50 MeVP52 (R) ACh 3 3.0 0.3% 91.8%
51 OCG02c (R) unclear 3 3.0 0.3% 92.1%
52 aMe10 (L) ACh 2 2.0 0.2% 92.3%
53 aMe17c (R) Glu 2 2.0 0.2% 92.5%
54 Cm21 (R) GABA 2 2.0 0.2% 92.7%
55 Cm31b (R) GABA 2 2.0 0.2% 92.9%
56 LC36 (R) ACh 2 2.0 0.2% 93.2%
57 Li30 (R) GABA 2 2.0 0.2% 93.4%
58 Li34b (R) GABA 2 2.0 0.2% 93.6%
59 LoVC19 (R) ACh 2 2.0 0.2% 93.8%
60 LoVCLo3 (R) OA 2 2.0 0.2% 94.0%
61 MeLo8 (R) GABA 2 2.0 0.2% 94.2%
62 MeVC2 (L) ACh 2 2.0 0.2% 94.4%
63 MeVCMe1 (R) ACh 2 2.0 0.2% 94.7%
64 MeVPMe3 (L) Glu 2 2.0 0.2% 94.9%
65 5-HTPMPV03 (L) 5HT 1 1.0 0.1% 95.0%
66 aMe10 (R) ACh 1 1.0 0.1% 95.1%
67 aMe17e (R) Glu 1 1.0 0.1% 95.2%
68 aMe22 (R) Glu 1 1.0 0.1% 95.3%
69 aMe8 (R) ACh 1 1.0 0.1% 95.4%
70 Cm11a (R) ACh 1 1.0 0.1% 95.5%
71 Cm26 (R) Glu 1 1.0 0.1% 95.6%
72 Cm28 (R) unclear 1 1.0 0.1% 95.7%
73 Cm32 (R) GABA 1 1.0 0.1% 95.8%
74 Dm2 (R) ACh 1 1.0 0.1% 95.9%
75 DN1a (R) unclear 1 1.0 0.1% 96.0%
76 DNp27 (R) unclear 1 1.0 0.1% 96.1%
77 Lawf1 (R) ACh 1 1.0 0.1% 96.3%
78 LC13 (R) ACh 1 1.0 0.1% 96.4%
79 LC46b (R) ACh 1 1.0 0.1% 96.5%
80 Li18b (R) GABA 1 1.0 0.1% 96.6%
81 Li39 (L) GABA 1 1.0 0.1% 96.7%
82 LoVC18 (R) Dop 1 1.0 0.1% 96.8%
83 LoVC20 (L) GABA 1 1.0 0.1% 96.9%
84 LoVC23 (L) GABA 1 1.0 0.1% 97.0%
85 LoVC25 (L) ACh 1 1.0 0.1% 97.1%
86 LoVCLo3 (L) OA 1 1.0 0.1% 97.2%
87 LoVP14 (R) ACh 1 1.0 0.1% 97.3%
88 LoVP43 (R) unclear 1 1.0 0.1% 97.4%
89 LoVP73 (R) unclear 1 1.0 0.1% 97.5%
90 LoVP96 (R) Glu 1 1.0 0.1% 97.6%
91 LPLC2 (R) ACh 1 1.0 0.1% 97.8%
92 LT55 (L) Glu 1 1.0 0.1% 97.9%
93 LT58 (R) Glu 1 1.0 0.1% 98.0%
94 LT70 (R) GABA 1 1.0 0.1% 98.1%
95 MeLo14 (R) Glu 1 1.0 0.1% 98.2%
96 MeLo2 (R) ACh 1 1.0 0.1% 98.3%
97 MeLo3a (R) ACh 1 1.0 0.1% 98.4%
98 MeLo3b (R) ACh 1 1.0 0.1% 98.5%
99 MeVCMe1 (L) ACh 1 1.0 0.1% 98.6%
100 MeVP10 (R) ACh 1 1.0 0.1% 98.7%
101 MeVP29 (R) ACh 1 1.0 0.1% 98.8%
102 MeVP3 (R) ACh 1 1.0 0.1% 98.9%
103 MeVP31 (R) ACh 1 1.0 0.1% 99.0%
104 MeVP42 (R) ACh 1 1.0 0.1% 99.1%
105 MeVP48 (R) unclear 1 1.0 0.1% 99.3%
106 MeVP9 (R) ACh 1 1.0 0.1% 99.4%
107 MeVPLo2 (L) ACh 1 1.0 0.1% 99.5%
108 MeVPLo2 (R) ACh 1 1.0 0.1% 99.6%
109 PLP211 (R) unclear 1 1.0 0.1% 99.7%
110 Pm13 (R) Glu 1 1.0 0.1% 99.8%
111 Tm16 (R) ACh 1 1.0 0.1% 99.9%
112 TmY10 (R) ACh 1 1.0 0.1% 100.0%

Outputs

  instance NT total connections connections /#SLP250 (R) % % cumu.
0 aMe10 (R) ACh 33 33.0 33.3% 33.3%
1 aMe1 (R) GABA 24 24.0 24.2% 57.6%
2 Cm35 (R) GABA 7 7.0 7.1% 64.6%
3 aMe5 (R) ACh 5 5.0 5.1% 69.7%
4 aMe17b (R) GABA 3 3.0 3.0% 72.7%
5 MeVP1 (R) ACh 3 3.0 3.0% 75.8%
6 Cm5 (R) GABA 2 2.0 2.0% 77.8%
7 Lat2 (R) unclear 2 2.0 2.0% 79.8%
8 Pm12 (R) Glu 2 2.0 2.0% 81.8%
9 TmY10 (R) ACh 2 2.0 2.0% 83.8%
10 aMe12 (R) ACh 1 1.0 1.0% 84.8%
11 aMe2 (R) Glu 1 1.0 1.0% 85.9%
12 Cm12 (R) GABA 1 1.0 1.0% 86.9%
13 Cm17 (R) GABA 1 1.0 1.0% 87.9%
14 Cm3 (R) GABA 1 1.0 1.0% 88.9%
15 Cm30 (R) GABA 1 1.0 1.0% 89.9%
16 Cm9 (R) Glu 1 1.0 1.0% 90.9%
17 LC10c-1 (R) ACh 1 1.0 1.0% 91.9%
18 LC12 (R) unclear 1 1.0 1.0% 92.9%
19 LT55 (R) Glu 1 1.0 1.0% 93.9%
20 MeLo1 (R) ACh 1 1.0 1.0% 94.9%
21 MeVC10 (L) ACh 1 1.0 1.0% 96.0%
22 MeVC22 (R) Glu 1 1.0 1.0% 97.0%
23 MeVC_unclear (R) Glu 1 1.0 1.0% 98.0%
24 MeVP42 (R) ACh 1 1.0 1.0% 99.0%
25 MeVPMe4 (L) Glu 1 1.0 1.0% 100.0%